Previous research works have shown that high PTTG1 expression could enhance breast cancer malignancy by augmenting breast cancer stem cell population and epithelial mesenchymal transition in a manner dependent on activation of the PI3K/AKT pathway (Yoon et al., 2012). The gene discussed is PTTG1; the disease is breast cancer.